- Home
- AVTX vs ELVA Comparison
AVTX vs ELVA Comparison
Compare AVTX & ELVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVTX
- ELVA
- Stock Information
- Founded
- AVTX 2011
- ELVA 1996
- Country
- AVTX United States
- ELVA Canada
- Employees
- AVTX N/A
- ELVA N/A
- Industry
- AVTX Biotechnology: Pharmaceutical Preparations
- ELVA
- Sector
- AVTX Health Care
- ELVA
- Exchange
- AVTX Nasdaq
- ELVA Nasdaq
- Market Cap
- AVTX 88.4M
- ELVA 91.8M
- IPO Year
- AVTX 2015
- ELVA N/A
- Fundamental
- Price
- AVTX $4.41
- ELVA $2.52
- Analyst Decision
- AVTX Strong Buy
- ELVA Strong Buy
- Analyst Count
- AVTX 7
- ELVA 5
- Target Price
- AVTX $34.33
- ELVA $6.10
- AVG Volume (30 Days)
- AVTX 69.6K
- ELVA 40.5K
- Earning Date
- AVTX 05-12-2025
- ELVA 05-12-2025
- Dividend Yield
- AVTX N/A
- ELVA N/A
- EPS Growth
- AVTX N/A
- ELVA N/A
- EPS
- AVTX N/A
- ELVA N/A
- Revenue
- AVTX $441,000.00
- ELVA $43,693,000.00
- Revenue This Year
- AVTX N/A
- ELVA $55.23
- Revenue Next Year
- AVTX N/A
- ELVA $63.75
- P/E Ratio
- AVTX N/A
- ELVA N/A
- Revenue Growth
- AVTX N/A
- ELVA N/A
- 52 Week Low
- AVTX $4.44
- ELVA $1.67
- 52 Week High
- AVTX $17.49
- ELVA $3.54
- Technical
- Relative Strength Index (RSI)
- AVTX 29.58
- ELVA 52.93
- Support Level
- AVTX $4.59
- ELVA $2.30
- Resistance Level
- AVTX $5.85
- ELVA $2.59
- Average True Range (ATR)
- AVTX 0.85
- ELVA 0.16
- MACD
- AVTX -0.21
- ELVA 0.01
- Stochastic Oscillator
- AVTX 2.41
- ELVA 60.00
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
About ELVA Electrovaya Inc.
Electrovaya Inc designs develop and manufacture proprietary lithium-ion batteries, battery systems, and battery-related products for energy storage, clean electric transportation and other specialized applications. It is a technology-focused company with extensive IP. The company generates revenue from the sale of batteries and battery systems. Business operations are segmented based on large format batteries and others. This technology offers enhanced safety and battery longevity. Geographically it earns key revenue from the United States.